Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001714899-25-000089
Filing Date
2025-04-17
Accepted
2025-04-17 16:07:55
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-17

Document Format Files

Seq Description Document Type Size
1 ARS fy2024denaliannualreport.pdf ARS 29820514
  Complete submission text file 0001714899-25-000089.txt   41064536
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8547
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38311 | Film No.: 25847343
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)